Trials / Recruiting
RecruitingNCT06778031
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
An Open, Multicenter Phase II Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open, multicenter Phase II clinical trial to evaluate the efficacy and safety of the SHR-A1811 combination in HER2 positive patients with locally advanced or metastatic biliary tract cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-A1811 | SHR-A1811. |
| DRUG | SHR-1316 | SHR-1316. |
| DRUG | SHR-8068 | SHR-8068. |
Timeline
- Start date
- 2025-02-26
- Primary completion
- 2028-06-01
- Completion
- 2028-09-01
- First posted
- 2025-01-16
- Last updated
- 2025-03-06
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06778031. Inclusion in this directory is not an endorsement.